# Erisyon

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/erisyon

- Industry: Biotechnology
- Headquarters: Austin, US
- Website: www.erisyon.com/
- Latest round: Seed (Nov 30, 2020)
- Investors on record: 1

## About

Founded in 2018, based in Texas, US, Erisyon, Inc., operates as a biotechnology company that offers various therapeutic solutions using DNA sequencing for the detection of diseases. In November 2020, Erisyon, Inc., raised seed funding from Research Bridge Partners with participation from individual investors. As of 2023, the company is led by its CEO, Talli Somekh.

The company offers single-molecule protein sequencing technology called fluorosequencing, which is used for the detection, treatment, and tracking of disease by analyzing individual molecules, providing unparalleled sensitivity and resolution.

It allows for precise counting of protein abundance, enhancing the accuracy of proteomic analysis.

## Funding rounds

- Seed, Nov 30, 2020 — Research Bridge Partners

## Investors

- Research Bridge Partners (https://capitalatlas.ai/funds/research-bridge-partners) — Seed